Adjustment in Medication Dose for Mild Asthma Sufferers Shows no Significant … – Opposing Views


Opposing Views

Adjustment in Medication Dose for Mild Asthma Sufferers Shows no Significant
Opposing Views
"We know daily inhaled corticosteroids work well in controlling asthma long term, but asthma control can change within short periods of time — with seasons, for example. Also, many patients with mild asthma are reluctant to take daily medication

View full post on asthma – Google News

Childhood asthma link shows it is never too soon for mums to quit smoking – News-Medical.net


Daily Mail

Childhood asthma link shows it is never too soon for mums to quit smoking
News-Medical.net
By Kirsty Oswald, medwireNews Reporter. Smoking during pregnancy increases the risk for asthma and wheezing in early childhood, even if children are not exposed to smoke after birth, a European study shows. Researchers found that the risk for asthma
Smoking during pregnancy linked with asthma in childrenFox News
Smoking during pregnancy may boost risk of asthma in kidsThe Courier-Journal
Smoking During Pregnancy Increases Wheeze and Asthma Risk in Preschool news Stories
Examiner.com –GlobalPost –Medical News Today
all 36 news articles »

View full post on asthma – Google News

New Haven DPW shows off new pollution-reducing exhaust filters for garbage trucks – New Haven Register

New Haven DPW shows off new pollution-reducing exhaust filters for garbage trucks
New Haven Register
By Alexandra Sanders, Register Staff NEW HAVEN — Just in time for Asthma Awareness Month, the city took a step Tuesday to improve air quality by reducing particulate emissions, a significant contributor to asthma. The city showcased one of six
Bye Bye, Belching Black SmokeNew Haven Independent

all 2 news articles »

View full post on asthma – Google News

AstraZeneca Symbicort shows similar safety profile as Budesonide for asthma – Pharmaceutical Business Review

AstraZeneca Symbicort shows similar safety profile as Budesonide for asthma
Pharmaceutical Business Review
AstraZeneca has published a new study that demonstrates that Symbicort Inhalation Aerosol 320/9 µg twice daily has a safety profile similar to Budesonide pressurized metered-dose inhaler (pMDI) 320 µg twice daily for asthma.
SYMBICORT® (budesonide/formoterol fumarate dihydrate) Long-Term Study Shows EON: Enhanced Online News (press release)

all 2 news articles »

View full post on asthma – Google News

SYMBICORT(R) (budesonide/formoterol fumarate dihydrate)Long-Term Study Shows … – MarketWatch (press release)

SYMBICORT(R) (budesonide/formoterol fumarate dihydrate)Long-Term Study Shows
MarketWatch (press release)
More than 22 million Americans are living with asthma, including 2.3+ million African Americans. "These findings provide important information about the use of SYMBICORT in African-American patients with persistent asthma, and may help guide healthcare
AstraZeneca (AZN) Says SYMBICORT Shows Similar Safety Profile to Budesonide in StreetInsider.com (subscription)

all 4 news articles »

View full post on asthma – Google News

Budesonide/Formoterol for Asthma Shows Cardiovascular Safety – Family Practice News Digital Network

Budesonide/Formoterol for Asthma Shows Cardiovascular Safety
Family Practice News Digital Network
ORLANDO – Budesonide/formoterol pressurized metered-dose inhaler demonstrated similar cardiovascular safety to that of budesonide treatment alone in a study of 742 black adolescents and adults with moderate to severe asthma. There has been concern that

View full post on asthma – Google News